NEWS

FacebookTwitter Google+LinkedIn

19.09 2014

Ginolis delivers an automatic quality control system for point-of-care skin cancer test manufacturing to Germany

Ginolis Ltd delivers an automatic quality control system based on the Ginolis Delilah robot platform to Würth Elektronik in Germany. This automated vision-based system ensures the quality of electronic chips used in the manufacturing of quick tests. The integration of the electronic component with the minimally invasive micro spike sensor is essential to ensure high-quality operation.

“This deal is a major opening for Ginolis in Germany, and we are very pleased about our cooperation with Würth Elektronik in point-of-case diagnostics test manufacturing,” Matti Koivu, VP Manufacturing Services from Ginolis, says.

More information:

Matti Koivu
VP, Manufacturing Services, Ginolis Ltd
Phone: +358 (400) 544 376
E-mail: .(JavaScript must be enabled to view this email address)

About Ginolis

Ginolis Ltd applies state of the art processes and technologies used within the electronics industry for development and manufacturing of MedTech and in vitro diagnostic (IVD) disposable products. The company offers its customers contract development and manufacturing of sophisticated and cost efficient micro-fabricated components, efficient automated assembly of the final products as well as turn-key standardized, modular and space-saving automated production solutions. Ginolis holds several patents and licenses for technologies in dispensing, microfluidics, electronic valves, optics and micro fabrication. Based on these patented technologies, Ginolis is also developing proprietary products that are sold to OEM customers. Ginolis is privately-held, with company roots going back to 2010. It has its headquarters in Oulu, Finland, and a subsidiary in Uppsala, Sweden.  Further information can be found at www.ginolis.com.